Valuation: Southern Acids (M)

Market Cap 420M 103M 89.45M 83.26M 76.44M 144M 9.82B 147M 981M 385M 4.89B 386M 378M 16.4B P/E 2025
11.4x
P/E 2026 11.1x
Enterprise Value -6.08M -1.49M -1.29M -1.2M -1.11M -2.09M -142M -2.12M -14.19M -5.57M -70.71M -5.59M -5.46M -237M EV / Sales 2025
0.05x
EV / Sales 2026 -0.01x
Free-Float
26.64%
Yield 2025
1.64%
Yield 2026 1.65%
1 day+1.66%
1 week-0.97%
1 month-2.23%
3 months-4.06%
6 months-3.46%
Current year-3.46%
1 week 3.02
Extreme 3.02
3.1
1 month 3.02
Extreme 3.02
3.12
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.6
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 47 2015-07-14
Director of Finance/CFO 58 2013-09-30
Chief Tech/Sci/R&D Officer 38 2014-07-15
Director TitleAgeSince
Director/Board Member 66 2005-08-09
Director/Board Member 59 2012-03-19
Chairman 79 2015-07-14
Change 5-day change 1-year change 3-year change Capi.($)
+1.66%-0.97%-11.01%-14.72% 101M
-0.23%+16.72%+50.95%+476.52% 6.39B
+0.55%-1.22%+25.00%+100.55% 1.71B
+10.02%+17.71%+34.02%+80.26% 799M
-0.46%-0.46%+37.71%+96.37% 557M
+3.23%+10.11%+25.64%+4.81% 550M
+2.18%+7.97%-17.73%-33.89% 478M
-2.79%+0.83%+5.74%+4.83% 395M
+2.61%+7.82%+39.88%-11.13% 364M
-2.75%+1.04%+3.46%+26.05% 300M
Average +1.40%+4.17%+19.37%+72.97% 1.16B
Weighted average by Cap. +0.79%+8.62%+37.69%+285.57%

Financials

2025 2026
Net sales 1.11B 271M 235M 219M 201M 380M 25.84B 386M 2.58B 1.01B 12.87B 1.02B 994M 43.14B 934M 229M 199M 185M 170M 321M 21.81B 326M 2.18B 855M 10.86B 858M 839M 36.42B
Net income 36.7M 8.98M 7.81M 7.27M 6.67M 12.6M 858M 12.8M 85.68M 33.63M 427M 33.74M 33M 1.43B 37.38M 9.15M 7.95M 7.4M 6.8M 12.84M 873M 13.03M 87.26M 34.25M 435M 34.36M 33.61M 1.46B
Net Debt -367M -89.8M -78.07M -72.66M -66.71M -126M -8.57B -128M -857M -336M -4.27B -337M -330M -14.31B -426M -104M -90.75M -84.47M -77.55M -146M -9.97B -149M -996M -391M -4.96B -392M -383M -16.64B
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,676
Date Price Change Volume
26-07-31 MYR 3.070 +1.66% 100
26-07-29 MYR 3.020 -0.33% 3,800
26-07-28 MYR 3.030 -1.30% 6,100
26-07-27 MYR 3.070 -0.97% 13,100
26-07-23 MYR 3.100 +1.31% 5,000